News
Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...
1d
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results